Market Summary | Major Indices | Market Movers | Market Sectors | Mutual Funds | A-Z Stock Listings
ETF Screener | World Markets | Currencies | CEO Wealthmeter | Oil / Energy | Metals
Treasury Rates | Calculators | My Watchlist | My Portfolio
         Symbol Lookup
OSIRIS THERAPEUTICS Add to My Watchlist (NSDQ: OSIR) 
Detailed Quote
News
Chart
SEC Filings
Profile
Historical
Options
     Osiris 8.65 +0.12 (+1.41%) 71,921
7015 Albert Einstein Drive
Columbia, MD 21046 US
(443) 545-1800
(410) 522-6999 fax
www.osiristx.com
CEO Dr. C. Randal Mills, Ph.D.
Auditor STEGMAN & COMPANY
Exchange Traded NQ
ISIN Number US68827R1086
CIK Number 1360886
NAICS Code 325414
Business Summary
A stem cell therapeutic company, which is focused on developing and marketing products to treat medical conditions in the inflammatory, orthopedic and cardiovascular areas.
Number of Employees 163
Share Fundamentals
Market Cap 283.48M
Shares Outstanding 32.77M
Float 19.29M
Short Interest 2.54M
Financial Strength
Revenue (TTM) $39,936,000
Earnings (TTM) -$8,892,000
Quick Ratio 1.8:1
Current Ratio 1.8:1
Total Debt/Equity 0:1
Profitability
Gross Margin 14.6%
EBITDA Margin -93.6%
Profit Margin -94.7%
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Real Time Stock News provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs